Ask the Doctor/Q&A

Ask the Doctor/Q&A How much control does a person with Parkinson’s have over his/her symptoms? One of the key...see more observations with movement in PD, which can be baffling for onlookers, is that automatic movements are affected. When a person with PD concentrates on their movements they are often able to make them more normal-appearing than […]

Read More

CLINICAL TRIAL ANNOUNCEMENT

: An Experimental, One-Time Gene Therapy for Parkinson’s Disease If your response to Parkinson’s disease medications has...see more become unpredictable or isn’t what it used to be, this clinical study may be an option that you should discuss with your doctor. The RESTORE-1 Clinical Study is evaluating an experimental, one-time gene therapy approach to […]

Read More

Research Updates

In September, APDA announced funding for cutting-edge research projects for the 2019-2020 academic year totaling $1.7 million....see more These grants, along with others that were submitted, were reviewed earlier this year by APDA’s Scientific Advisory Board (SAB). The annual SAB meeting is also a time to hear updates on previously-funded research. David Standaert, MD, […]

Read More

Coloring outside the lines of traditional PD therapies

Ā New Program Offers Creative Outlet, Improves PD Symptoms Ā An innovative new...see more program offers a host of benefits for people with Parkinson’s who have challenges in visual perception and spatial relations, affecting their ability to move through the world. Most current PD treatment regimens don’t focus on this […]

Read More

Creating Connections

  Beyond the Doctor’s Visit: Taking Parkinson’s Care to the Next Level ā€œGame changing.ā€ That’s how Robin...see more Kornhaber, Senior Vice President, National Programs and Partnerships at the American Parkinson Disease Association (APDA), describes APDA Information and Referral (I&R) Centers. APDA I&R Centers are at medical institutions across the country where APDA supports either […]

Read More